GRM5 and Cognitive impairment: Excessive metabotropic glutamate receptor 5 (mGluR5) signalling has been proposed to be responsible for the psychiatric and neurological symptoms of FXS, including cognitive deficits, seizures, anxiety, perseverative movements and social deficits.